In women, lung cancer mortality should outpace breast cancer mortality

A report from Public Health France reports on cancer in 2017 to outline the future of these diseases and their management. Among the teachings, lung cancer is becoming the leading cause of death in women, compared to breast cancer, which is more common.

The time is up, especially for cancers. The goal of Public Health France is to anticipate the short-term future cancers, as well as the potential deaths that result.
The main teaching of this report intervenes on the side of the cancers of the woman. A long-time "leader" in the rankings, breast cancer should no longer stay in the lead in terms of induced mortality. The remarkable medical and therapeutic advances combined with the best prevention have indeed curbed the mortality that results.
Added to this is the arrival in force of a plague that has been sweeping the female sex for several decades now: lung cancer. The explanation is simple, women are smoking more and more and younger.

Status quo for men

The other sex experienced 214,000 new cases of cancer in 2017. The most frequent remain substantially the same: prostate cancer (48,400 new cases estimated in 2013, no projection possible for 2017), lung (32,300 new cases in 2017) or colon-rectum (24,000 new cases). Men succumb more to colon cancer than women. In fact, of the 150,000 deaths of the year, 84,000 were men, or 56%.
But equality is at least effective in the disease. If prostate cancer is the most common, it is one of the best cared for because the most deadly in the male remains, again, lung cancer.

It should be recalled, however, that these projections reflect hypotheses and may be validated by subsequent trends that will be published in 2019.

Video: NCCS "Current Issues in Cancer Care" Cancer Policy Advocate Training (December 2019).